Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

prostate-specific antigen

  • Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study
    Open Access
    Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study
    Letizia Calderoni, Elisa Maietti, Andrea Farolfi, Riccardo Mei, Karly S. Louie, Michael Groaning and Stefano Fanti
    Journal of Nuclear Medicine June 1, 2023, 64 (6) 910-917; DOI: https://doi.org/10.2967/jnumed.122.264964
  • Phase III Study of <sup>18</sup>F-PSMA-1007 Versus <sup>18</sup>F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
    Open Access
    Phase III Study of 18F-PSMA-1007 Versus 18F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
    Pierre Olivier, Anne-Laure Giraudet, Andrea Skanjeti, Charles Merlin, Pierre Weinmann, Ines Rudolph, Alexander Hoepping and Mathieu Gauthé
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 579-585; DOI: https://doi.org/10.2967/jnumed.122.264743
  • Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus <sup>18</sup>F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial
    You have access
    Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial
    Ismaheel O. Lawal, Ashesh B. Jani, Omotayo A. Adediran, Subir Goyal, Olayinka A. Abiodun-Ojo, Vishal R. Dhere, Charles V. Marcus, Shreyas S. Joshi, Viraj A. Master, Pretesh R. Patel, Mark Goodman, Joseph W. Shelton, Omer Kucuk, Bruce Hershatter, Bridget Fielder, Raghuveer K. Halkar and David M. Schuster
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 586-591; DOI: https://doi.org/10.2967/jnumed.122.264832
  • Effects of <sup>225</sup>Ac-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis
    You have access
    Effects of 225Ac-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis
    Dong Yun Lee and Yong-il Kim
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 840-846; DOI: https://doi.org/10.2967/jnumed.121.262017
  • You have access
    Early Prostate-Specific Antigen Changes and Clinical Outcome After 177Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer
    Andrei Gafita, Matthias M. Heck, Isabel Rauscher, Robert Tauber, Lisena Cala, Charlott Franz, Calogero D’Alessandria, Margitta Retz, Wolfgang A. Weber and Matthias Eiber
    Journal of Nuclear Medicine October 1, 2020, 61 (10) 1476-1483; DOI: https://doi.org/10.2967/jnumed.119.240242
  • You have access
    11C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series
    Laure Michaud, Karim A. Touijer, Audrey Mauguen, Michael J. Zelefsky, Michael J. Morris, Serge K. Lyashschenko, Jeremy C. Durack, John L. Humm, Wolfgang A. Weber and Heiko Schöder
    Journal of Nuclear Medicine June 1, 2020, 61 (6) 827-833; DOI: https://doi.org/10.2967/jnumed.119.233098
  • You have access
    Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL
    Benedikt Kranzbühler, Julian Müller, Anton S. Becker, Helena I. Garcia Schüler, Urs Muehlematter, Christian D. Fankhauser, Sarah Kedzia, Matthias Guckenberger, Philipp A. Kaufmann, Daniel Eberli and Irene A. Burger
    Journal of Nuclear Medicine February 1, 2020, 61 (2) 194-201; DOI: https://doi.org/10.2967/jnumed.118.225276
SNMMI

© 2025 SNMMI

Powered by HighWire